A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

August 31, 2007

Conditions
Asthma
Interventions
DRUG

Budesonide/formoterol pMDI

DRUG

Budesonide HFA pMDI

Trial Locations (44)

Unknown

Research Site, Tuscumbia

Research Site, Fort Smith

Research Site, Long Beach

Research Site, Orange

Research Site, Riverside

Research Site, Sacramento

Research Site, San Diego

Research Site, San Jose

Research Site, Colorado Springs

Research Site, Denver

Research Site, Valrico

Research Site, River Forest

Research Site, Council Bluffs

Research Site, Topeka

Research Site, Wichita

Research Site, Bowling Green

Research Site, Florence

Research Site, Metairie

Research Site, City of Saint Peters

Research Site, St Louis

Research Site, Butte

Research Site, Omaha

Research Site, Papillion

Research Site, Las Vegas

Research Site, Skillman

Research Site, Summit

Research Site, Albuquerque

Research Site, New York

Research Site, North Syracuse

Research Site, Rochester

Research Site, Greensboro

Research Site, Mooresville

Research Site, Oklahoma City

Research Site, Tulsa

Research Site, Collegeville

Research Site, Charleston

Research Site, Greenville

Research Site, Spartanburg

Research Site, Union

Research Site, Dallas

Research Site, South Burlington

Research Site, Bellingham

Research Site, Spokane

Research Site, Tacoma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY